IDiyas

For the Inventor, By the Inventor

Pipersville, PA, United States of America

R Richard Goehring

USPTO Granted Patents = 32 

 

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 517(Granted Patents)


Location History:

  • Pipersville, PA (US) (2002 - 2016)
  • Yardley, PA (US) (2013 - 2016)
  • Henderson, TX (US) (2015 - 2018)

Company Filing History:

goldMedal19 out of 545 
 
Purdue Pharma L.p.
 patents
silverMedal10 out of 270 
 
Euro-celtique S.a.
 patents
bronzeMedal4 out of 1,001 
 
Shionogi Company Limited
 patents
4. 2 out of 82 
 
Scios Inc.
 patents
5. 1 out of 2 
 
Purde Pharma L.p.
 patents
where one patent can have more than one assignee

Years Active: 2002-2018

Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents
1. 10030021 - Spirocyclic morphinans and use thereof (2018-07-24),
2. 9975854 - Benzomorphan analogs and use thereof (2018-05-22),
3. 9527840 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2016-12-27),
4. 9382260 - Buprenorphine analogs (2016-07-05),
5. 9278967 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2016-03-08),
6. 9273048 - Spirocyclic morphinans and their use (2016-03-01),
7. 9168255 - Quinazoline compounds as sodium channel blockers (2015-10-27),
8. 9045435 - Quinazoline compounds as sodium channel blockers (2015-06-02),
9. 8987287 - Spirocyclic morphinans and their use (2015-03-24),
10. 8846929 - Substituted-quinoxaline-type piperidine compounds and the uses thereof (2014-09-30),
11. 8637502 - 2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain (2014-01-28),
12. 8530494 - Buprenophine analogs (2013-09-10),
13. 8252815 - Nociceptin analogs (2012-08-28),
14. 8110602 - Compounds comprising heterocyclic-substituted piperidine for treating pain (2012-02-07),
15. 7943643 - Aryl substituted pyridines and the use thereof (2011-05-17),

Title: A Look into the Innovations of R Richard Goehring

Introduction:

R Richard Goehring, a prolific inventor based in Pipersville, PA (US), has made significant contributions to the field of pharmaceuticals with his impressive portfolio of 32 patents. His latest patents showcase his expertise in developing compounds for treating various disorders responsive to opioid receptor modulation.

Latest Patents:

1. Spirocyclic morphinans and use thereof: Goehring's invention provides compounds of Formula I and other related formulae, along with their pharmaceutical applications for the treatment of conditions modulated by opioid receptors, particularly in pain management.

2. Benzomorphan analogs and use thereof: Another notable patent by Goehring includes compounds represented by Formula I or I', designed for treating pain, constipation, and other related conditions through opioid and/or ORL-1 receptor activity modulation.

Career Highlights:

Goehring has worked with renowned pharmaceutical companies such as Purdue Pharma L.P. and Euro-Celtique S.A., showcasing his expertise and dedication to innovation in the pharmaceutical industry. His patents reflect his deep understanding of drug development and pain management therapies.

Collaborations:

Throughout his career, Goehring has collaborated with esteemed colleagues like Donald J. Kyle and Sam Victory, leveraging their collective knowledge and expertise to drive groundbreaking research and development in the field of pharmaceuticals.

Conclusion:

R Richard Goehring's remarkable innovations in pharmaceutical compounds stand as a testament to his ingenuity and commitment to advancing the field of pain management and opioid receptor modulation. His patents not only demonstrate his technical prowess but also highlight his unwavering passion for creating impactful solutions in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…